3rd Quarter - Termination

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for TETHYS BIOSCIENCE

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—
Terminated
Jul 31, 2012

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Termination (this page) Aug 24, 2012 $10,000 Replaced
3rd Quarter - Termination Amendment Dec 31, 2012 $10,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Regulation and reimbursement of laboratory developed tests.

LobbyistCovered position, as disclosed
NICHOLAS G CAVAROCCHI —
JENNIFER RACHEL LEIB —
KATHRYN SCHUBERT —

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to health care policy and the prevention of diabetes. P.L. 111-148-/P.L. 111-152, Affordable Care Act Regulation and reimbursement of laboratory developed tests.

LobbyistCovered position, as disclosed
NICHOLAS G CAVAROCCHI —
JENNIFER RACHEL LEIB —
KATHRYN SCHUBERT —

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.